FDA reverses course on rejection of Moderna's mRNA flu vaccine
cyrusradfar Wednesday, February 18, 2026
Summary
The FDA initially rejected Moderna's mRNA-based flu vaccine, but has now decided to review the vaccine. This reversal comes after the agency faced criticism for its initial decision, which was seen as a surprising move given the success of Moderna's COVID-19 vaccine.
8
1
Summary
arstechnica.com